产品特点
1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Hippotwin 439 mg/g oral paste for horses.
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
COMPOSITION PER GRAM
ACTIVE SUBSTANCE:
Pyrantel embonate (equivalent to 152.2 mg of pyrantel) 439 mg
EXCIPIENT(S):
Methyl parahydroxybenzoate(E 218)
1 mg
Propyl parahydroxybenzoate (E 216).
0.3 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Oral paste
Yellow, viscous, oily paste
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Horses, ponies and foals (of over 8 weeks of age).
4.2
INDICATIONS FOR USE,SPECIFYING THE TARGET SPECIES
Infestations with adult stages of roundworm, particularly ascarids (_Parascaris equorum_), small
strongyles (_Cyathostomum spp., Triodontophorus spp_.) and large strongyles (_Strongylus edentatus, _
_Strongylus equinus, Strongylus vulgaris_), seatworm/pinworm (_Oxyuris equi_) and tapeworm
(_Anoplocephala perfoliata_) in horses, ponies and foals.
The efficacy towards _Anoplocephala perfoliata_ is variable.
4.3
CONTRAINDICATIONS
Do not use in animals known to be hypersensitive to the active substance.
4.4
SPECIAL WARNINGS
Treatment against tapeworms should only be undertaken when tapeworms have been diagnosed.
Resistance to pyrantel embonate has been reported in cyathostomins in horses. Therefore the use of
this product should be based on local (regional, farm) epidemiological information about susceptibility of
cyathostomins and recommendations on how to limit further selection for resistance to anthelmintics.
Care should be tak
阅读完整的文件